Table 3

Frequencies of the−15Thr→Ala signal peptide genotypes in healthy controls and in CF patients with and without plasma α1-antichymotrypsin (ACT) deficiency

ACT genotype CF + deficient ACT (n=10) CF + normal ACT (n=42) Controls (n=45)
AA (GG) (%)6 (60%)20 (47.6%)11 (24.4%)
AT (GA) (%)2 (20%)15 (35.7%)26 (57.8%)
TT (AA) (%)2 (20%)7 (16.7%)8 (17.8%)
ACT A (G) allele0.70.650.53
ACT T (A) allele0.30.350.47